Literature DB >> 9244141

Modeling in frequency domain used for assessment of in vivo dissolution profile.

M Durisová1, L Dedík.   

Abstract

PURPOSE: To present a model-dependent approach for the assessment of the in vivo drug dissolution profile based on in vitro data for the multiple unit dosage form, as an alternative to the numerical method proposed in the study by Hayashi et al., Pharm Res. 12:1333-1337 (1995).
METHODS: The data for aspirin granules administered to healthy subjects obtained in the above mentioned study were re-evaluated. The subject dissolution system was considered to consist of two subsystems connected in series, i.e. the subsystem describing the gastric-emptying process and the subsystem describing the intestinal dissolution process. The frequency response method was used to model the subject dissolution system.
RESULTS: The model in vivo dissolution profile of aspirin, assessed as the integral of the model weighting function of the subject dissolution system, was in agreement with the in vivo cumulative absorption profile calculated by the Wagner-Nelson method.
CONCLUSIONS: Comparison of dynamic properties of the subject dissolution system with the subsystem describing the gastric-emptying process yielded quantitative confirmation of the decisive role of the gastric-emptying process in the in vivo drug dissolution after administration in the multi unit dosage form.

Entities:  

Mesh:

Year:  1997        PMID: 9244141     DOI: 10.1023/a:1012139530965

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

1.  Bioequivalence.

Authors:  A Rescigno
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

2.  KINETIC ANALYSIS OF BLOOD LEVELS AND URINARY EXCRETION IN THE ABSORPTIVE PHASE AFTER SINGLE DOSES OF DRUG.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1964-11       Impact factor: 3.534

3.  Frequency response method in pharmacokinetics.

Authors:  L Dedík; M Durisová
Journal:  J Pharmacokinet Biopharm       Date:  1994-08

4.  CXT: a programme for analysis of linear dynamic systems in the frequency domain.

Authors:  L Dedík; M Durisová
Journal:  Int J Biomed Comput       Date:  1995-05

Review 5.  Bioequivalence and generic prescribing: an industrial view.

Authors:  A Pidgen
Journal:  J Pharm Pharmacol       Date:  1996-01       Impact factor: 3.765

6.  CXT-MAIN: a software package for determination of the analytical form of the pharmacokinetic system weighting function.

Authors:  L Dedík; M Durisová
Journal:  Comput Methods Programs Biomed       Date:  1996-11       Impact factor: 5.428

7.  New evaluation method for in vitro/in vivo correlation of enteric-coated multiple unit dosage forms.

Authors:  T Hayashi; T Ogura; Y Takagishi
Journal:  Pharm Res       Date:  1995-09       Impact factor: 4.200

8.  Building a structured model of a complex pharmacokinetic system with time delays.

Authors:  M Durisová; L Dedík; M Balan
Journal:  Bull Math Biol       Date:  1995-11       Impact factor: 1.758

  8 in total
  6 in total

1.  Predictive ability of level A in vitro-in vivo correlation for ringcap controlled-release acetaminophen tablets.

Authors:  J T Dalton; A B Straughn; D A Dickason; G P Grandolfi
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

2.  Bias in the Wagner-Nelson estimate of the fraction of drug absorbed.

Authors:  Yibin Wang; Jerry Nedelman
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

3.  Classical Michaelis-Menten and system theory approach to modeling metabolite formation kinetics.

Authors:  Jovan Popović
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Jul-Sep       Impact factor: 2.441

4.  Spline functions in convolutional modeling of verapamil bioavailability and bioequivalence. I: conceptual and numerical issues.

Authors:  J Popović
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Apr-Jun       Impact factor: 2.441

5.  A system-approach method for the adjustment of time-varying continuous drug infusion in individual patients: a simulation study.

Authors:  Mária Durisová; Ladislav Dedík
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-12       Impact factor: 2.745

6.  Physiologically based structure of mean residence time.

Authors:  Mária Durišová
Journal:  ScientificWorldJournal       Date:  2012-04-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.